FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joel Kremer

Research Profile

Disorders

Rheumatoid Arthritis

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Joints

Devices

Placebos

Co-author Network

Publications

TOP 3
Dimitrios Pappas; Robert M Plenge; Joel M Kremer; Cheongeun Oh; Jeffrey D Greenberg
Association of rheumatoid arthritis risk alleles with response to anti-TNF biologics: results from the CORRONA registry and meta-analysis.
Edward Clark Keystone; Joel M Kremer; Allison Luo; Anthony Russell; Rene Swanink; Carlos Abud-Mendoza; Richard Aranda; Jane Box; Ingrid Delaet; Mario Garza Elizondo; Sheila Gujrathi; Michael Luggen
Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study.
Jasvinder A Singh; Maria Suarez-Almazor; Elizabeth R Volkmann; Kevin L Winthrop; John T Schousboe; Harsh Agrawal; Sangmee Bae; Timothy Beukelman; Aseem Bharat; Claire Bombardier; S Louis Bridges; W Winn Chatham; Jeffrey R Curtis; Maxime Dougados; Daniel E Furst; Archana Jain; Arthur F Kavanaugh; Dinesh Khanna; Charles M King; Karen S Kolba; Joel M Kremer; Amye L Leong; Eric L Matteson; Larry W Moreland; Eileen Moynihan; Amy S Mudano; James O'Dell; Nivedita M Patkar; Harold E Paulus; Kenneth G Saag
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joel Kremer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Dimitrios Pappas; Robert M Plenge; Joel M Kremer; Cheongeun Oh; Jeffrey D Greenberg
Association of rheumatoid arthritis risk alleles with response to anti-TNF biologics: results from the CORRONA registry and meta-analysis.
Inflammation 2013;36(2):279-84.
2012: Edward Clark Keystone; Joel M Kremer; Allison Luo; Anthony Russell; Rene Swanink; Carlos Abud-Mendoza; Richard Aranda; Jane Box; Ingrid Delaet; Mario Garza Elizondo; Sheila Gujrathi; Michael Luggen
Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study.
Annals of the rheumatic diseases 2012;71(6):857-61.
2012: Jasvinder A Singh; Maria Suarez-Almazor; Elizabeth R Volkmann; Kevin L Winthrop; John T Schousboe; Harsh Agrawal; Sangmee Bae; Timothy Beukelman; Aseem Bharat; Claire Bombardier; S Louis Bridges; W Winn Chatham; Jeffrey R Curtis; Maxime Dougados; Daniel E Furst; Archana Jain; Arthur F Kavanaugh; Dinesh Khanna; Charles M King; Karen S Kolba; Joel M Kremer; Amye L Leong; Eric L Matteson; Larry W Moreland; Eileen Moynihan; Amy S Mudano; James O'Dell; Nivedita M Patkar; Harold E Paulus; Kenneth G Saag
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.
Arthritis care & research 2012;64(5):625-39.
2011: Joel M Kremer; Tracy Li; Charles Peterfy; Anthony S Russell; Jacek Szechinski; René Westhovens; Xianhuang Zhou; Carlos Abud-Mendoza; Richard Aranda; Jean-Claude Becker; Paul Emery; Harry K Genant
Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial.
Annals of the rheumatic diseases 2011;70(10):1826-30.
2010: Jeffrey R Curtis; Timothy Beukelman; A Onofrei; S Cassell; J D Greenberg; A Kavanaugh; G Reed; Vibeke Strand; Joel M Kremer
Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Annals of the rheumatic diseases 2010;69(1):43-7.
2008: Joel M Kremer
COMET's path, and the new biologicals in rheumatoid arthritis.
Lancet 2008;372(9636):347-8.
2008: Joel M Kremer; Allan Gibofsky; Jeffrey D Greenberg
The role of drug and disease registries in rheumatic disease epidemiology.
Current opinion in rheumatology 2008;20(2):123-30.
2006: Larry W Moreland; Michael E Weinblatt; Edward C Keystone; Joel M Kremer; Richard W Martin; Michael H Schiff; James B Whitmore; Barbara A White
Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
The Journal of rheumatology 2006;33(5):854-61.
2006: Michael H Weisman; Daniel E Furst; Grace S Park; Joel M Kremer; Katie M Smith; Daniel J Wallace; Jacques R Caldwell; Thierry Dervieux
Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis.
Arthritis and rheumatism 2006;54(2):607-12.
2004: Joel M Kremer; Grant W Cannon
Benefit/risk of leflunomide in rheumatoid arthritis.
Clinical and experimental rheumatology 2004;22(5 Suppl 35):S95-100.
2004: Mark C Genovese; Joel M Kremer
Treatment of rheumatoid arthritis with etanercept.
Rheumatic diseases clinics of North America 2004;30(2):311-28, vi-vii.
2004: Grant W Cannon; Joel M Kremer
Leflunomide.
Rheumatic diseases clinics of North America 2004;30(2):295-309, vi.
2004: Edward C Keystone; Michael H Schiff; Joel M Kremer; Shelly Kafka; Michael Lovy; Todd DeVries; Daniel J Burge
Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Arthritis and rheumatism 2004;50(2):353-63.
2003: Joel M Kremer; Joseph S Habros; Karen S Kolba; Jeffrey L Kaine; Mary Ann Borton; Laurel J Mengle-Gaw; Benjamin D Schwartz; Wayne Wisemandle; Qais A Mekki
Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
Arthritis and rheumatism 2003;48(10):2763-8.
2003: Joel M Kremer; Michael E Weinblatt; Arthur D Bankhurst; Ken J Bulpitt; Roy Fleischmann; Christopher G Jackson; Kelly M Atkins; Anyang Feng; Daniel J Burge
Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
Arthritis and rheumatism 2003;48(6):1493-9.
2002: Joel M Kremer; Mark C Genovese; Grant W Cannon; Jacques R Caldwell; John J Cush; Daniel E Furst; Michael Luggen; Edward C Keystone; Michael H Weisman; William M Bensen; Jeffrey L Kaine; Eric M Ruderman; Patricia Coleman; David L Curtis; Elliot J Kopp; Seth M Kantor; Jonathan Waltuck; Herbert B Lindsley; Joseph A Markenson; Vibeke Strand; Bruce Crawford; Indra Fernando; Karen Simpson; Joan M Bathon
Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.
Annals of internal medicine 2002;137(9):726-33.
2001: Theodore Pincus; Gary G Koch; Tuulikki Sokka; J Lefkowith; Frederick Wolfe; Joanne M Jordan; Gheorghe Luta; Leigh F Callahan; X Wang; Todd A Schwartz; S B Abramson; Jacques R Caldwell; R A Harrell; Joel M Kremer; Richard L Lautzenheiser; Joseph A Markenson; T J Schnitzer; A Weaver; P Cummins; A Wilson; S Morant; John G Fort
A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee.
Arthritis and rheumatism 2001;44(7):1587-98.
2001: Frederick Wolfe; John J Cush; James R O'Dell; Arthur Kavanaugh; Joel M Kremer; Nancy E Lane; Larry W Moreland; H E Paulus; Theodore Pincus; A S Russell; K R Wilskie
Consensus recommendations for the assessment and treatment of rheumatoid arthritis.
The Journal of rheumatology 2001;28(6):1423-30.
2001: Joel M Kremer
Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
Annals of internal medicine 2001;134(8):695-706.
2000: Joel M Kremer
n-3 fatty acid supplements in rheumatoid arthritis.
The American journal of clinical nutrition 2000;71(1 Suppl):349S-51S.
1999: Theodore Pincus; James R O'Dell; Joel M Kremer
Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy.
Annals of internal medicine 1999;131(10):768-74.
1999: P J Mroczkowski; M E Weinblatt; Joel M Kremer
Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis.
Clinical and experimental rheumatology 1999;17(6 Suppl 18):S66-8.
1999: Joel M Kremer
Methotrexate and emerging therapies.
Clinical and experimental rheumatology 1999;17(6 Suppl 18):S43-6.
1999: Joel M Kremer
Methotrexate and leflunomide: biochemical basis for combination therapy in the treatment of rheumatoid arthritis.
Seminars in arthritis and rheumatism 1999;29(1):14-26.
1999: Michael E Weinblatt; Joel M Kremer; Jonathan S Coblyn; agnes lee maier; Simon M Helfgott; M Morrell; V M Byrne; M V Kaymakcian; Vibeke Strand
Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
Arthritis and rheumatism 1999;42(7):1322-8.
1999: Michael E Weinblatt; Joel M Kremer; Arthur D Bankhurst; Ken J Bulpitt; Roy Fleischmann; R I Fox; C G Jackson; M Lange; Daniel J Burge
A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
The New England journal of medicine 1999;340(4):253-9.
1999: Nancy J Olsen; Vibeke Strand; Joel M Kremer
Leflunomide for the treatment of rheumatoid arthritis.
Bulletin on the rheumatic diseases 1999;48(8):1-4.
1998: M L Barnett; Joel M Kremer; E William St Clair; Daniel O Clegg; Daniel E Furst; Michael Weisman; M J Fletcher; S Chasan-Taber; E Finger; A Morales; CH Le; DE Trentham
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.
Arthritis and rheumatism 1998;41(2):290-7.
1997: Joel M Kremer; Graciela S Alarcón; Michael E Weinblatt; M V Kaymakcian; M Macaluso; Grant W Cannon; W R Palmer; J S Sundy; E William St Clair; R W Alexander; G J Smith; C A Axiotis
Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review.
Arthritis and rheumatism 1997;40(10):1829-37.
1997: Graciela S Alarcón; Joel M Kremer; M Macaluso; Michael E Weinblatt; Grant W Cannon; W R Palmer; E William St Clair; J S Sundy; R W Alexander; G J Smith; C A Axiotis
Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group.
Annals of internal medicine 1997;127(5):356-64.
1997: Joel M Kremer
Safety, efficacy, and mortality in a long-term cohort of patients with rheumatoid arthritis taking methotrexate: followup after a mean of 13.3 years.
Arthritis and rheumatism 1997;40(5):984-5.
1996: Joel M Kremer; H Malamood; B Maliakkal; J B Rodgers; Jeffrey S Ross; J A Cooper
Fish oil dietary supplementation for prevention of indomethacin induced gastric and small bowel toxicity in healthy volunteers.
The Journal of rheumatology 1996;23(10):1770-3.
1996: Joel M Kremer; J Bigaouette
Nutrient intake of patients with rheumatoid arthritis is deficient in pyridoxine, zinc, copper, and magnesium.
The Journal of rheumatology 1996;23(6):990-4.
1996: Joel M Kremer
Treatment of systemic sclerosis with topical tretinoin: report of two cases.
Arthritis and rheumatism 1996;39(6):1070.
1996: Joel M Kremer; D E Furst; M E Weinblatt; S D Blotner
Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis.
The Journal of rheumatology 1996;23(3):459-61.
1996: Joel M Kremer
Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids.
Lipids 1996;31 Suppl():S243-7.
1995: Joel M Kremer; R A Hamilton
The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg.
The Journal of rheumatology 1995;22(11):2072-7.
1995: Joel M Kremer; G I Kaye; N W Kaye; K G Ishak; C A Axiotis
Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Followup over long treatment intervals and correlation with clinical and laboratory variables.
Arthritis and rheumatism 1995;38(9):1194-203.
1995: Joel M Kremer; D A Lawrence; G F Petrillo; L L Litts; P M Mullaly; R I Rynes; R P Stocker; N Parhami; N S Greenstein; B R Fuchs
Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates.
Arthritis and rheumatism 1995;38(8):1107-14.
1995: S D Fink; Joel M Kremer
Successful treatment of interstitial lung disease in systemic lupus erythematosus with methotrexate.
The Journal of rheumatology 1995;22(5):967-9.
1995: Joel M Kremer; J M Davies; R I Rynes; S Fink; D A Lawrence; G F Petrillo; P M Mullaly
Every-other-week methotrexate in patients with rheumatoid arthritis. A double-blind, placebo-controlled prospective study.
Arthritis and rheumatism 1995;38(5):601-7.
1995: R A Hamilton; Joel M Kremer
The effects of food on methotrexate absorption.
The Journal of rheumatology 1995;22(4):630-2.
1995: Joel M Kremer; G F Petrillo; R A Hamilton
Examination of pharmacokinetic variables in a cohort of patients with rheumatoid arthritis beginning therapy with methotrexate compared with a cohort receiving the drug for a mean of 81 months.
The Journal of rheumatology 1995;22(1):41-4.
1995: Joel M Kremer; G F Petrillo; R A Hamilton
Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
The Journal of rheumatology 1995;22(1):38-40.
1994: Michael E Weinblatt; B F Germain; Joel M Kremer; B A Wall; M H Weisman; agnes lee maier; Jonathan S Coblyn
Lack of a renal-protective effect of misoprostol in rheumatoid arthritis patients receiving cyclosporin A. Results of a randomized, placebo-controlled trial.
Arthritis and rheumatism 1994;37(9):1321-5.
1994: S D Fink; Joel M Kremer
Cutaneous and musculoskeletal features, diagnostic modalities, and immunopathology in sarcoidosis.
Current opinion in rheumatology 1994;6(1):78-81.
1992: Michael E Weinblatt; Joel M Kremer; Jonathan S Coblyn; S Helfgott; agnes lee maier; G Petrillo; B Henson; P Rubin; R Sperling
Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.
The Journal of rheumatology 1992;19(10):1537-41.
1992: Joel M Kremer; R Koff
A debate: should patients with rheumatoid arthritis on methotrexate undergo liver biopsies?
Seminars in arthritis and rheumatism 1992;21(6):376-86.
1992: Joel M Kremer; C T Phelps
Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months.
Arthritis and rheumatism 1992;35(2):138-45.
1991: Joel M Kremer; D R Robinson
Studies of dietary supplementation with omega 3 fatty acids in patients with rheumatoid arthritis.
World review of nutrition and dietetics 1991;66():367-82.
1990: Joel M Kremer
Severe rheumatoid arthritis: current options in drug therapy.
Geriatrics 1990;45(12):43-8.
1990: Joel M Kremer; D A Lawrence; W Jubiz; R DiGiacomo; R Rynes; L E Bartholomew; M Sherman
Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects.
Arthritis and rheumatism 1990;33(6):810-20.
1989: Joel M Kremer; G I Kaye
Electron microscopic analysis of sequential liver biopsy samples from patients with rheumatoid arthritis. Correlation with light microscopic findings.
Arthritis and rheumatism 1989;32(10):1202-13.
1989: Joel M Kremer
Methotrexate 1989--the evolving story.
The Journal of rheumatology 1989;16(3):261-3.
1989: Joel M Kremer; R G Lee; K G Tolman
Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples.
Arthritis and rheumatism 1989;32(2):121-7.
1989: R A DiGiacomo; Joel M Kremer; D M Shah
Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.
The American journal of medicine 1989;86(2):158-64.
1988: Joel M Kremer; J K Lee
A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months.
Arthritis and rheumatism 1988;31(5):577-84.
1987: Joel M Kremer; R I Rynes; L E Bartholomew
Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy. Double-blind study.
The American journal of medicine 1987;82(4):781-6.
1987: Joel M Kremer; W Jubiz; A Michalek; R I Rynes; L E Bartholomew; J Bigaouette; M Timchalk; D Beeler; L Lininger
Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study.
Annals of internal medicine 1987;106(4):497-503.
1985: Joel M Kremer; J Bigauoette; A V Michalek; M A Timchalk; L Lininger; R I Rynes; C Huyck; J Zieminski; L E Bartholomew
Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis.
Lancet 1985;1(8422):184-7.
1981: Joel M Kremer; R I Rynes; L E Bartholomew; L D Rodichok; E W Pelton; E A Block; R B Tassinari; R J Silver
Non-organic non-psychotic psychopathology (NONPP) in patients with systemic lupus erythematosus.
Seminars in arthritis and rheumatism 1981;11(1):182-9.